1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNovartis Gene Therapies supports research that provides valuable information regarding the safety, efficacy, pharmacology, and tolerability of products in their therapeutic areas of expertise (rare and life-threatening neurological genetic diseases).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Academic medical centers, hospitals, medical/professional associations, medical schools and other health science schools, patient support/advocacy groups, universities/colleges, and tax-exempt organizations. Confirm the full requirements in the official notice before applying.
Investigator-Initiated Trials (IIT), Research Collaborations and Consortia is funded by Novartis Gene Therapies. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Novartis Gene Therapies Investigator-Initiated Trials (IITs), Research Collaborations and Consortia is sponsored by Novartis Gene Therapies. Novartis Gene Therapies supports investigator-initiated trials (IIT), research collaborations and consortia that provide valuable information regarding the safety, efficacy, pharmacology, and tolerability of products. They provide grants exclusively in their therapeutic areas of expertise (rare and life-threatening neurological genetic diseases) and based on the scientific merit of the investigator's proposal.
Research Grants (Therapeutic Areas of Expertise) is sponsored by Novartis Gene Therapies. Novartis Gene Therapies provides grants for investigator-initiated research exclusively in their therapeutic areas of expertise (rare and life-threatening neurological genetic diseases) and based on the scientific merit of the investigator's proposal. The research must be intended to contribute knowledge to the medical community with a reasonable and appropriate budget.